Framework for QC Outsource Testing

Tender description

CPI has a requirement, which will to be to establish a Multi Supplier Framework agreement for the QC outsource testing initially at our National Biologics Manufacturing Centre, but services may be extended across other CPI Centre’s as and when required throughout the period of the Framework. The Tender is split into two Lots. Lot 1 - Routine Testing/Monitoring of Samples. Lot 2 - GMP Analytical Testing Services Lot 2: GMP Analyitical Testing Services GMP analytical testing services are required for QC release testing of nucleic acid therapeutics including mRNA Active Pharmaceutical Ingredient (API) and lipid nanoparticle containing mRNA Bulk Drug Substance (BDS). Upon successful award, the requirements of this Tender can be procured by any department, branch, division, business unit, site, subsidiary or any other legal entity of CPI, against any existing or future project and/or order, whether or not it is part funded by the European Regional Development Fund (ERDF) Competitive Programme 2014 – 2020, or any subsequent replacement Competitive Programme